Orexo AB (publ) (STO:ORX)
15.24
+0.04 (0.26%)
Jul 24, 2026, 5:29 PM CET
Orexo AB Revenue
Orexo AB had revenue of 3.50M SEK in the quarter ending June 30, 2026, a decrease of -27.08%. This brings the company's revenue in the last twelve months to 122.00M, down -15.69% year-over-year. In the year 2025, Orexo AB had annual revenue of 26.00M, down -12.46%.
Revenue (ttm)
122.00M
Revenue Growth
-15.69%
P/S Ratio
32.06
Revenue / Employee
272.13K
Employees
61
Market Cap
532.21M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.00M | -3.70M | -12.46% |
| Dec 31, 2024 | 29.70M | -609.10M | -95.35% |
| Dec 31, 2023 | 638.80M | 14.50M | 2.32% |
| Dec 31, 2022 | 624.30M | 59.30M | 10.50% |
| Dec 31, 2021 | 565.00M | -98.60M | -14.86% |
| Dec 31, 2020 | 663.60M | -181.20M | -21.45% |
| Dec 31, 2019 | 844.80M | 61.70M | 7.88% |
| Dec 31, 2018 | 783.10M | 139.40M | 21.66% |
| Dec 31, 2017 | 643.70M | -62.20M | -8.81% |
| Dec 31, 2016 | 705.90M | 59.70M | 9.24% |
| Dec 31, 2015 | 646.20M | 75.88M | 13.31% |
| Dec 31, 2014 | 570.32M | 140.96M | 32.83% |
| Dec 31, 2013 | 429.36M | 103.08M | 31.59% |
| Dec 31, 2012 | 326.28M | 126.66M | 63.45% |
| Dec 31, 2011 | 199.61M | -10.89M | -5.17% |
| Dec 31, 2010 | 210.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EQL Pharma AB | 432.66M |
| Cinclus Pharma Holding AB | 67.51M |
| Cereno Scientific AB | 66.82M |
| Nanexa AB | 54.41M |
| Enzymatica AB | 51.93M |
| Newbury Pharmaceuticals AB | 35.02M |
| Moberg Pharma AB | 14.59M |
| Enorama Pharma AB | 2.18M |
Orexo AB News
- 10 days ago - Orexo AB Earnings Call Transcript: Q2 2026 - Transcripts
- 10 days ago - Orexo AB Quarterly report: Q2 2026 - Filings
- 10 days ago - Orexo AB Slides: Q2 2026 - Filings
- 2 months ago - Orexo AB Slides: ABGSC Investor Days - Filings
- 3 months ago - Orexo AB Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Orexo AB Quarterly report: Q1 2026 - Filings
- 3 months ago - Orexo AB Slides: Q1 2026 - Filings
- 4 months ago - Orexo AB Transcript: R&D Day - Transcripts